Tech Company Financing Transactions

FogPharma Funding Round

On 3/1/2024, FogPharma secured $145 million in Series E funding from Nextech Invest, Arch Venture Partners and Catalio Capital Management.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

30 Acorn Park Dr.
Cambridge, MA 02140
USA

Phone

(617) 945-9510

Website

www.fogpharma.com

Email Address

[email protected]

Overview

FogPharma was born from the scientific and entrepreneurial vision of founder Greg Verdine, a pioneer in the discovery and development of new drug classes that 'drug the undruggable.' FogPharma's cell-penetrating miniproteins (CPMPs) are a broad new class of medicines that can drug targets beyond the reach of conventional therapeutics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Gregory Verdine

        

Chief Financial Officer

Tony Gibney

        

Chief Operating Officer

WeiQing Zhou

        

Chief Scientific Officer

Howard Stern

        

Vice President

Jonathan Hurov

        

Vice President

Martin Tremblay

        

VP - Finance

Stephen Fair

        

VP - Human Resources

Sandra Smith

        

Browse more venture capital transactions:

Prev: 3/1/2024: KIT-AR venture capital transaction
Next: 3/1/2024: BuildBear Labs venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary